137 related articles for article (PubMed ID: 6191999)
1. The role of the N-terminus in the active conformation of the substance P analogues.
Murakoshi T; Yanagisawa M; Kitada C; Fujino M; Otsuka M
Eur J Pharmacol; 1983 May; 90(1):133-7. PubMed ID: 6191999
[TBL] [Abstract][Full Text] [Related]
2. Novel substance P analogues inhibit circular muscle contraction of guinea pig ileum and depolarization of new born rat spinal cord induced by substance P.
Mochizuki T; Ohshima K; Kuwahara A; Yanagisawa M; Otsuka M; Yanaihara N
Regul Pept; 1993 Jul; 46(1-2):321-5. PubMed ID: 7692526
[No Abstract] [Full Text] [Related]
3. Analogues of substance P. Peptides containing D-amino acid residues in various positions of substance P and displaying agonist or receptor selective antagonist effects.
Dutta AS; Gormley JJ; Graham AS; Briggs I; Growcott JW; Jamieson A
J Med Chem; 1986 Jul; 29(7):1163-71. PubMed ID: 2433442
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles.
Munekata E; Kubo K; Tanaka H; Osakada F
Peptides; 1987; 8(1):169-73. PubMed ID: 2437548
[TBL] [Abstract][Full Text] [Related]
5. [Synergistic receptor subtypes: an explanation for reserve receptors and for different intrinsic activities of full and partial agonists. Studies on the effect of substance P and its analogs on guinea pig ileum].
Bergmann J
Biomed Biochim Acta; 1983; 42(7-8):1005-18. PubMed ID: 6197064
[TBL] [Abstract][Full Text] [Related]
6. Distinct classes of substance P receptors revealed by a comparison of the activities of substance P and some of its segments.
Teichberg VI; Cohen S; Blumberg S
Regul Pept; 1981 Feb; 1(5):327-33. PubMed ID: 6166965
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of C-terminal hexa- and heptapeptide substance P antagonists as studied in the guinea-pig ileum.
Hörig J; Schultheiss H
Eur J Pharmacol; 1984 Oct; 105(1-2):65-72. PubMed ID: 6208044
[TBL] [Abstract][Full Text] [Related]
8. Tissue selectivity of substance P alkyl esters: suggesting multiple receptors.
Watson SP; Sandberg BE; Hanley MR; Iversen LL
Eur J Pharmacol; 1983 Jan; 87(1):77-84. PubMed ID: 6188620
[TBL] [Abstract][Full Text] [Related]
9. Antagonists of substance P. Further modifications of substance P antagonists obtained by replacing either positions 7, 9 or 7, 8 and 11 of SP with D-amino acid residues.
Dutta AS; Gormley JJ; Graham AS; Briggs I; Growcott JW; Jamieson A
J Med Chem; 1986 Jul; 29(7):1171-8. PubMed ID: 2433443
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of substance P C-terminal hexapeptide and heptapeptide analogues.
Stavropoulos G; Karagiannis K; Cordopatis P; Halle D; Gilon C; Bar-Akiva G; Selinger Z; Chorev M
Int J Pept Protein Res; 1991 Mar; 37(3):180-4. PubMed ID: 1714423
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of NK1 substance P selective agonists by modifying the methionyl residue.
Poulos C; Antoniou M; Patacchini R; Maggi CA; Pegoraro S; Rovero P
Neuropeptides; 1994 Jul; 27(1):27-9. PubMed ID: 7526260
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of potent agonists of substance P by replacement of Met11 with Glu(OBzl) and N-terminal glutamine with Glp of the C-terminal hexapeptide and heptapeptide of substance P.
Stavropoulos G; Karagiannis K; Anagnostides S; Ministrouski I; Selinger Z; Chorev M
Int J Pept Protein Res; 1995 Jun; 45(6):508-13. PubMed ID: 7558580
[TBL] [Abstract][Full Text] [Related]
14. Specific recognition of SP or NKB receptors by analogues of SP substituted at positions 8 and 9.
Lavielle S; Chassaing G; Julien S; Marquet A; Bergström L; Beaujouan JC; Torrens Y; Glowinski J
Eur J Pharmacol; 1986 Jun; 125(3):461-2. PubMed ID: 2426130
[No Abstract] [Full Text] [Related]
15. Use of substance P fragments to differentiate substance P receptors of different tissues.
Piercey MF; Dobry PJ; Einspahr FJ; Schroeder LA; Masiques N
Regul Pept; 1982 May; 3(5-6):337-49. PubMed ID: 6180459
[TBL] [Abstract][Full Text] [Related]
16. Substance P and analogues: biological activity and degradation.
Teichberg VI; Blumberg S
Prog Biochem Pharmacol; 1980; 16():84-94. PubMed ID: 6160595
[TBL] [Abstract][Full Text] [Related]
17. Contracting activity of C-terminal fragments and a C-terminal hexapeptide analogue of substance P on non-stimulated and electrically stimulated isolated guinea-pig ileum.
Konecka AM; Sadowski B; Sroczyńska I; Lipkowski AW; Majewski T; Drabarek S
Gen Pharmacol; 1981; 12(2):119-21. PubMed ID: 6162713
[No Abstract] [Full Text] [Related]
18. Evaluation of (D-Pro2, D-Trp7,9)-substance P as an antagonist of substance P responses in the rat central nervous system.
Salt TE; De Vries GJ; Rodriguez RE; Cahusac PM; Morris R; Hill RG
Neurosci Lett; 1982 Jun; 30(3):291-5. PubMed ID: 6180363
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of substance P methyl ester.
Cascieri MA; Goldenberg MM; Liang T
Mol Pharmacol; 1981 Nov; 20(3):457-9. PubMed ID: 6173735
[No Abstract] [Full Text] [Related]
20. Synthesis of substance P analogs with arginine in position eleven.
Sofuku S; Torigoe K; Muramatsu I
Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4144-8. PubMed ID: 6085034
[No Abstract] [Full Text] [Related]
[Next] [New Search]
